Patent · US Active

Compounds useful for treating a Mannheimia haemolytica or Histophilus somni infection

US11034650B2 · kind B2 · utility

1Cited by

0References

4Claims

0Family size

Assignee

Intervet Inc. · US

Inventors

Michael Berger · Wiesbaden, DE
Thorsten Meyer · Bad Kreuznach, DE
Joachim Ullrich · Stuttgart, DE
Ralf Warrass · Alzey, DE

Key dates

Filing date	Dec 22, 2017
Grant date	Jun 15, 2021
Priority date	—
Expiry date	Dec 22, 2037

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A40/70
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present invention discloses compounds of formula (I) that are useful in the treatment of respiratory diseases of animals, especially Bovine or Swine Respiratory disease (BRD and SRD).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.